A new study suggests that the latest advances in DBS (deep brain stimulation) for Parkinson’s disease can induce treatments for conditions like OCD (obsessive-compulsive disorder), depression, and Gilles de la Tourette syndrome. The scientists from the HUG (Geneva University Hospitals), University of Tübingen, University of Geneva, and the Wyss Center for Bio and Neuroengineering, states that bi-directional electrodes that could fuel and outline from deep brain structures can have applications further than Parkinson’s disease. The study was published in Nature Reviews Neurology.
Other bi-directional BCIs (brain-computer interfaces) have been in advancement in last few years, particularly for the real-time indication processing of neuronal movement to permit power of a robotic arm openly from the brain in individuals having paralysis. Professor John Donoghue—Director of the Wyss Center—said, “Captivatingly the fields of BCIs for activity restoration and DBS for Parkinson’s disease have advanced largely autonomously. DBS researchers tend to be neurosurgeons or neurologists while BCI researchers are mostly roboticists, neuroscientists, and engineers. By functioning together and sharing data, we can potentially enlarge the reach of this technology as it can assist more people.” Reportedly, DBS is normally utilized to alleviate the rigidity and shaking linked with Parkinson’s disease.
On a similar note, recently, a study showed that Parkinson’s treatment delivered a power-up to brain cell “batteries.” Researchers have found evidence of how a Parkinson’s disease therapy—known as DBS—aids in tackling symptoms. The early-stage research, by scientists at ICL (Imperial College London), proposes the therapy boosts the strength and number of brain cell “batteries” known as mitochondria. These batteries in return offer power to brain cells, which might aid in reducing problems with tremors and movement.